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Both caloric restriction (CR) and resveratrol (RSV) have beneficial effects on obesity.
However, the biochemical pathways that mediate these beneficial effects might be
complex and interconnected and have not been fully elucidated. To reveal the common
therapeutic mechanism of CR and RSV, we performed a comparative transcriptome
analysis of adipose tissues from diet-induced obese (DIO) zebrafish and obese humans.
We identified nine genes in DIO zebrafish and seven genes in obese humans whose
expressions were regulated by CR and RSV. Although the gene lists did not overlap
except for one gene, the gene ontologies enriched in the gene lists were highly
overlapped, and included genes involved in adipocyte differentiation, lipid storage
and lipid metabolism. Bioinformatic analysis of cis-regulatory sequences of these
genes revealed that their transcriptional regulators also overlapped, including EP300,
HDAC2, CEBPB, CEBPD, FOXA1, and FOXA2. We also identified 15 and 46 genes
that were dysregulated in the adipose tissue of DIO zebrafish and obese humans,
respectively. Bioinformatics analysis identified EP300, HDAC2, and CEBPB as common
transcriptional regulators for these genes. EP300 is a histone and lysyl acetyltransferase
that modulates the function of histone and various proteins including CEBPB, CEBPD,
FOXA1, and FOXA2. We demonstrated that adiposity in larval zebrafish was significantly
reduced by C646, an inhibitor of EP300 that antagonizes acetyl-CoA. The reduction
of adiposity by C646 was not significantly different from that induced by RSV or co-
treatment of C646 and RSV. These results indicate that the inhibition of EP300 might be
a common therapeutic mechanism between CR and RSV in adipose tissues of obese
individuals.
Keywords: resveratrol, caloric restriction, obesity, adipose tissue, ep300, zebrafish, comparative transcriptome,
systems pharmacology
Abbreviations: AcCoA, acetyl coenzyme A; BMI, body mass index; CR, caloric restriction; DIO, diet-induced obese; dpf,
days post-fertilization; FXR, farnesoid X receptor; GEO, Gene Expression Omnibus; mpf, months post-fertilization; OF,
overfeeding; RSV, resveratrol; TF, transcription factors; TGs, triglycerides.
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Introduction
According to the World Health Organization, an estimated
310 million people worldwide are obese (Bessesen, 2008). Such
estimates are particularly alarming given the strong association
between obesity and various adverse health consequences,
including atherosclerosis, hypertension, type 2 diabetes and
certain types of cancer (Bessesen, 2008). CR can alleviate these
deleterious conditions in obesity (Guarente, 2013). However,
eating less for the sake of creating a desirable metabolic proﬁle
is unlikely to gain widespread compliance (Timmers et al.,
2011). Accordingly, there has been an increasing interest in
identifying compounds that elicit the beneﬁcial eﬀects of CR
without requiring reduced calorie intake.
Resveratrol is thought to mimic the eﬀects of CR in obesity
(Guarente, 2013). In mice on a high-fat diet, RSV diminished
total body fat content and decreased depots of epididymal,
inguinal and retroperitoneal white adipose tissue (Lagouge et al.,
2006). In obese Zucker rats, the administration of RSV resulted in
a signiﬁcant reduction in plasma TGs, free fatty acids, cholesterol,
and liver TGs when compared with untreated obese Zucker rats
(Rivera et al., 2009).
The mechanism of how RSV exerts these favorable eﬀects
was proposed to be related to the induction of genes encoding
oxidative phosphorylation and mitochondrial biogenesis
molecules (Chung et al., 2012; de Ligt et al., 2015). Numerous
data indicate that the activation of NAD+-dependent protein
deacetylase, SIRT1, is pivotal for the beneﬁcial eﬀect of RSV
(Chung et al., 2012; de Ligt et al., 2015). SIRT1 catalyzes,
among others, deacetylation and the activation of peroxisome
proliferator gamma coactivator-1α, a cofactor in mitochondrial
biogenesis (Chung et al., 2012; de Ligt et al., 2015). However, the
biochemical pathways proposed to mediate the beneﬁcial eﬀects
of RSV are highly interconnected (Chung et al., 2012), suggesting
that systems pharmacology might be required to fully elucidate
the therapeutic mechanism of RSV in obesity.
It was demonstrated that CR increases the expression of SIRT1
protein (Cohen et al., 2004) and that the beneﬁcial eﬀects of
CR are mediated via SIRT1 (Picard et al., 2004). However, the
general up-regulation of Sirt1 expression was challenged by a
study showing CR-regulated Sirt1 expression was tissue speciﬁc
in mice (Chen et al., 2008). Moreover, SIRT1-independent eﬀects
of CR were also reported (Kaeberlein and Powers, 2007). These
ﬁndings suggest there common therapeutic mechanisms between
CR and RSV might be both dependent and independent of
SIRT1.
To identify the common therapeutic mechanism between CR
and RSV, we performed comparative transcriptome analysis of
adipose tissues from DIO zebraﬁsh and obese humans with or
without CR or RSV. Combined with bioinformatics analysis, we
identiﬁed EP300, a histone and lysyl acetyltransferase, as a master
regulator for genes dysregulated in obesity and normalized by CR
and RSV. We also demonstrated that the inhibition of EP300 by
a competitive inhibitor of acetyl-CoA reduced the adiposity of
larval zebraﬁsh. These results suggest that the inhibition of EP300
might be a common therapeutic mechanism of CR and RSV on
adiposity in obesity.
Materials and Methods
Ethics Statement
Mie University Institutional Animal Care and Use Committee
guidelines state that no approval is required for experiments
using zebraﬁsh. However, animal experiments described in this
manuscript conform to the ethical guidelines established by the
Institutional Animal Care and Use Committee at Mie University.
Compounds and Reagents
Resveratrol and C646 were purchased from Sigma (St. Louis,
MO, USA). Nile Red was purchased from Tokyo Kasei (Tokyo,
Japan); 2-phenoxyethanol and TG L-type assay were purchased
from Wako (Tokyo, Japan).
Zebrafish Husbandry
Zebraﬁsh were maintained according to the methods described
by Westerﬁeld (2007) with some modiﬁcation. Brieﬂy, zebraﬁsh
were raised at 28.5 ± 0.5◦C with a 14 h/10 h light/dark cycle.
Embryos were obtained via natural mating and cultured in
0.3 × Danieau solution [19.3 mM NaCl, 0.23 mM KCl, 0.13 mM
MgSO4, 0.2 mM Ca(NO3)2, 1.7 mM HEPES, pH 7.2]. To induce
the adult DIO model, we used a transparent zebraﬁsh mutant
lineMieKomachi 001 (MK001) that was created by crossing nacre
and rose. For the experiments using larva, we used an albino
zebraﬁsh line that was obtained from the Max Planck Institute
for Developmental Biology (Tübingen, Germany).
Adult DIO Zebrafish Model
Female zebraﬁsh at 4mpf were assigned into three dietary groups:
OF, OF + RSV, and control, with ﬁve ﬁsh per 2-L tank. Zebraﬁsh
in the OF andOF+RSV groups were fed three times per day with
freshly hatched Artemia (corresponding to 60 mg cysts/ﬁsh/day).
Zebraﬁsh in the control group were fed freshly hatched Artemia
(corresponding to 5 mg cysts/ﬁsh/day) once per day. Zebraﬁsh
in the OF + RSV groups were fed with gluten containing RSV
(corresponding to 20 μg /ﬁsh/day) at 20 min before feeding
Artemia in the morning. Zebraﬁsh in the OF and control groups
were fed with gluten without RSV at 20 min before feeding
Artemia in the morning. Gluten with or without RSV were
prepared as previously described (Zang et al., 2011). The body
weight and length of zebraﬁsh were measured weekly throughout
the study. Zebraﬁsh length was measured from the head to the
end of the body. Blood collection and TG measurement in the
plasma were performed as described previously (Oka et al., 2010).
Staining visceral adipose tissues was performed as previously
described (Oka et al., 2010) except for the concentration of Nile
Red (1 μg /ml) and the staining time (30 min). After staining,
the visceral adipose tissues were observed with a ﬂuorescence
microscope (MZ 16F, Leica, Tokyo, Japan) using a GFP2 ﬁlter
(Leica). The ﬂuorescent intensity of Nile Red was calculated using
Volocity 3D Image Analysis Software (Perkin-Elmer, Cambridge,
MA, USA).
Assessment of Adiposity in Larval Zebrafish
Zebraﬁsh at three dpf were treated with 2μMC646, 200μMRSV
or 2 μM C646 and 200 μM RSV for 48 h. After the treatment,
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zebraﬁsh were stained with Nile Red (5 ng/ml) for 30 min. After
staining, zebraﬁsh were rinsed in 0.3 × Danieau solution and
anesthetized with 2-phenoxyethanol (500 ppm). In vivo imaging
of the zebraﬁsh was performed using a ﬂuorescence microscope
(SMZ25, Nikon, Tokyo, Japan) with a GFP-L ﬁlter (Nikon). The
area stained with Nile Red in the abdomen was measured using
Volocity (Perkin-Elmer).
Transcriptome Analysis of Visceral Adipose
Tissues of Female DIO Zebrafish
The visceral adipose tissue of female DIO zebraﬁsh overfed
Artemia for 1 week (OF 1 w) or 5 weeks (OF 5 w), or
overfed Artemia for 5 weeks with RSV (OF + RSV 5 w),
were stained with Nile Red and collected by surgical
extraction under a ﬂuorescence microscope. The visceral
adipose tissue was stored in RNA-later (Applied Biosystems,
Foster City, CA, USA). Total RNA was then extracted using
an RNeasy Plus Micro Kit (Qiagen, Valencia, CA, USA),
qualiﬁed by an Agilent Bioanalyzer 2100 (Agilent, Santa
Clara, CA, USA) and quantiﬁed using a spectrophotometer
(NanoDrop ND-100, Wilmington, DE, USA). Fifty nanograms
of total RNA from each visceral adipose tissue depot were
converted into labeled cRNA using the Low RNA Input
Fluorescent Linear Ampliﬁcation Kit (Agilent). Cy3-labeled
cRNA (860 ng) was hybridized to Agilent Zebraﬁsh Whole
Genome Oligo Microarrays (G2519F) according to the
manufacturer’s protocol. The hybridized microarrays were
scanned (Agilent G2565BA) and analyzed using Feature
Extraction software (Agilent). The data were normalized using
Limma (Ritchie et al., 2015), a package in Bioconductor. Probes
that passed four criteria (gIsSaturated, gIsFeatNonUnifOL,
gIsPosAndSignif, gIsWellAboveBG) across the dataset were
used for further analysis. RankProd analysis (Hong et al.,
2006) was performed to identify diﬀerentially expressed genes
between two groups by calculating the false discovery rate
(FDR). Diﬀerentially expressed genes (FDR < 30%) were
then converted to human orthologs using the Life Science
Knowledge Bank (World Fusion, Tokyo, Japan). The gene
symbols of human orthologs were used for functional analysis.
The gene symbols of human orthologs were used for functional
analysis. The microarray data has been deposited to GEO as
GSE70281.
Transcriptome Analysis of Adipose Tissue in
Male DIO Zebrafish and Obese Humans
We downloaded transcriptome data from the GEO analyzing
visceral adipose tissues of male DIO zebraﬁsh with and
without CR (GSE18566; Oka et al., 2010), subcutaneous adipose
tissues of obese humans with and without CR (GSE35710;
Nookaew et al., 2013), subcutaneous adipose tissues of obese
human males with and without RSV (GSE42432; Konings
et al., 2014), subcutaneous adipose tissue of obese human
females (GSE44000; Deng et al., 2013), and subcutaneous
adipose tissue of obese human males (GSE29718; Tam et al.,
2011).
For the Agilent array (GSE18566 and GSE44000),
transcriptome data were normalized using Limma (Ritchie et al.,
2015) and the probes that passed four criteria (gIsSaturated,
gIsFeatNonUnifOL, gIsPosAndSignif, gIsWellAboveBG) across
the dataset were used for further analysis. For the aﬀymetrix
array, the transcriptome data were normalized using “aﬀy”
(Bolstad et al., 2003) for GSE35710 or “oligo” (Carvalho et al.,
2007) for GSE29718 and GSE42432. Data normalized by “aﬀy”
were ﬁltered based on the presence-absence call and probes that
were present or marginal across the dataset were used for further
analysis. Data normalized by “oligo” were ﬁltered based on the
normalized signal and probes with a normalized signal>3 across
the dataset were used for further analysis. RankProd analysis
(Hong et al., 2006) was performed to identify diﬀerentially
expressed genes between two groups by calculating the FDR.
FDR30% was used as the threshold. For transcriptome analysis
of zebraﬁsh, diﬀerentially expressed genes were converted to
human orthologs using the Life Science Knowledge Bank (World
Fusion, Tokyo, Japan).
Identification of Transcriptional Regulators
using iRegulon
iRegulon (Janky et al., 2014) exploits the fact that genes that
are co-regulated by the same TF commonly share binding sites
for the TF and uses gene sets derived from ENCODE ChIP-seq
data. We used iRegulon as an application in Cytoscape (Shannon
et al., 2003). The lists of diﬀerentially expressed genes shown
in Supplementary Table S1 were subjected to iRegulon and
used to predict their transcriptional regulators using the default
setting. The predicted transcriptional regulators with normalized
enrichment scores (NES)>3 are shown in Supplementary Table
S4 (Sheets 1–4) and used for further analysis.
Identification of Transcriptional Regulators
using Pathway Studio
Pathway Studio (Nikitin et al., 2003) uses gene sets derived
from natural language processing based text mining of published
literature, including a gene set for transcriptional regulators,
composed of geneswhose promoters the transcriptional regulator
bound to and genes whose expression were regulated by the
transcriptional regulator. The lists of diﬀerentially expressed
genes shown in Supplementary Table S1 were subjected
to Pathway Studio and used to predict their transcriptional
regulators using the subnetwork enrichment analysis for
“expression target”. The predicted transcriptional regulators with
p < 5.0 × 10−3 are shown in Supplementary Table S5 (Sheets
1–4) and were used for further analysis.
Identification of Cell Processes Enriched in a
Gene List using Pathway Studio
The lists of diﬀerentially expressed genes were subjected to
Pathway Studio and used to predict cell processes related
to the lists using the subnetwork enrichment analysis with
p< 5.0 × 10−3 as the threshold.
K-Means Clustering
K-means clustering was performed using MultiExperiment
Viewer v4.8 (Howe et al., 2011).
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Statistical Analysis
Statistical analysis (analysis of variance followed by Tukey’s
multiple comparisons test) was performed using Prism 6.0
(GraphPad Software, San Diego, CA, USA).
Results
Resveratrol Reduces Plasma Triglyceride and
Visceral Fat in Diet-Induced Obese Zebrafish
We previously demonstrated that CR after OF signiﬁcantly
lowered both plasma TG and visceral adiposity in zebraﬁsh (Oka
et al., 2010). In this study, we ﬁrst examined whether RSV
could also exert these eﬀects in the DIO zebraﬁsh model. Adult
female zebraﬁsh were overfed with freshly hatched nauplii of
Artemia that have a relatively high fat content compared with
ﬂake foods (Oka et al., 2010) with and without RSV treatment
(20 μg/day, 40 mg/kg body weight/day in 0.5 g zebraﬁsh).
The BMI of OF zebraﬁsh was signiﬁcantly increased compared
with the BMI of control zebraﬁsh after 1 week (Supplementary
Figure S1A). The BMI of zebraﬁsh overfed with Artemia and
treated with RSV (OF + RSV) was also signiﬁcantly increased
compared with the BMI of control zebraﬁsh. However, the BMI
of OF + RSV zebraﬁsh was not signiﬁcantly diﬀerent from that
of OF zebraﬁsh. We then examined the eﬀects of RSV on plasma
TG. As shown in Supplementary Figure S1B, plasma TG in
OF zebraﬁsh was signiﬁcantly increased compared with that of
control zebraﬁsh. In contrast, plasma TG levels in OF + RSV
zebraﬁsh were signiﬁcantly lower than in OF zebraﬁsh. We
also examined the eﬀects of RSV on visceral adiposity in DIO
zebraﬁsh, which can be visualized by Nile Red staining (Oka et al.,
2010). As shown in Supplementary Figure S1C, the ﬂuorescent
intensity of Nile Red in OF zebraﬁsh was signiﬁcantly higher
than in control zebraﬁsh. The ﬂuorescent intensity of Nile Red
in OF + RSV zebraﬁsh was signiﬁcantly lower than in OF
zebraﬁsh. These results suggest that RSV can reduce plasma
TG and adiposity in DIO zebraﬁsh, consistent with previous
reports in mammalian obesity (Rocha et al., 2009; Timmers et al.,
2011).
Identification of Transcriptional Regulators for
Genes Commonly Regulated by RSV and CR in
DIO Zebrafish
To identify common mechanisms of action between RSV and
CR, we compared transcriptome data of visceral adipose tissue
in DIO zebraﬁsh with RSV or CR (Oka et al., 2010). Although
the correlation of change in gene expression between RSV
and CR was low (Figure 1A), we identiﬁed nine genes in
common (Figure 1B and Supplementary Table S1, Sheet 1)
from 27 and 528 genes whose expression were changed by RSV
(Supplementary Table S2, Sheet 1) and CR (Supplementary
Table S2, Sheet 2), respectively. Gene ontology analysis revealed
that 56 cell processes, including lipid peroxidation, lipid
storage, and energy homeostasis, were enriched in the nine
identiﬁed genes (Supplementary Table S3, Sheet 1). To reveal
the molecular mechanism involved in the regulation of the
expression of the nine common genes, we used iRegulon
(Janky et al., 2014) to identify master regulators of the co-
expressed genes based on the genome-wide ENCODE ChIP-
seq data. iRegulon identiﬁed 20 transcriptional regulators for
the nine genes with a NES >3 (Supplementary Table S4,
Sheet 1). The network between these transcriptional regulators
and their target genes is shown in Figure 1C. To validate
the network identiﬁed by iRegulon, we used Pathway Studio
(Nikitin et al., 2003) to identify the master regulators of co-
expressed genes using natural language processing based text
mining. Pathway Studio identiﬁed 50 regulators for the nine
common genes (Supplementary Table S5, Sheet 1). Seven
regulators were overlapped between iRegulon and Pathway
Studio data. The network between the seven regulators and
their target genes identiﬁed by Pathway Studio is shown
in Figure 1D. The overlapping network correlated well
with the data identiﬁed by iRegulon. For example, Pathway
Studio identiﬁed FOXA1/FOXA2 as positive regulators of
IGFBP1, TF, and UCP3. iRegulon also identiﬁed these three
genes as targets of FOXA1/FOXA2 Supplementary Table S4,
Sheet 1).
Identification of Transcriptional Regulators for
Genes Commonly Regulated by RSV and CR in
Obese Humans
We then applied this analysis to determine the common
mechanism of action of RSV and CR in adipose tissues of obese
humans. We analyzed the transcriptome data of subcutaneous
adipose tissues from obese humans with and without RSV
(Konings et al., 2014) or CR (Nookaew et al., 2013) deposited
to GEO as GSE42432 and GSE35710, respectively. GSE42432
contained data from males only, whereas GSE35710 contained
data from both females and males. The correlation of gene
expression between RSV and CR was low (Figure 2A, left and
middle), which is consistent with the result in DIO zebraﬁsh
(Figure 1A), while the correlation between female and male
CR was high (r = 0.87, p < 1 × 10−4, Figure 2A, right). We
identiﬁed seven genes in common (Figure 2B, Supplementary
Table S1, Sheet 2) among 597 genes with altered expression
by RSV (Supplementary Table S2, Sheet 3), and 391 and
1,017 genes with altered expression by CR in females and
males, respectively (Supplementary Table S2, Sheets 4 and
5). Gene ontology analysis revealed that 177 cell processes,
including lipid metabolism, lipid degradation, andmitochondrial
depolarization were enriched in the seven genes (Supplementary
Table S3, Sheet 2). Although only one gene (transferrin) was
overlapped between the nine and seven common genes in
zebraﬁsh and humans, respectively (Supplementary Table S1,
Sheets 1 and 2), 36 gene ontologies were overlapped between
the 56 and 177 gene ontologies in zebraﬁsh and humans,
respectively (Supplementary Table S3, Sheets 1 and 2). iRegulon
identiﬁed 19 transcriptional regulators for the seven genes
(Supplementary Table S4, Sheet 2). The network between these
transcriptional regulator and their targets is shown in Figure 2C.
Pathway Studio identiﬁed 34 regulators for the seven common
genes (Supplementary Table S5, Sheet 2). Three regulators
were overlapped between data from the iRegulon and Pathway
Studio analyses. The network between the three regulators
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FIGURE 1 | Identification of transcriptional regulators for genes with changed expression levels common to RSV and CR in DIO zebrafish.
(A) Correlation of gene expression changes induced by RSV and CR in DIO zebrafish. (B) Venn diagram of the numbers of DEG by RSV and CR in DIO zebrafish.
(C) A regulatory network identified by iRegulon for the nine genes common between the RSV and CR groups. Genes shown in blue and red are decreased and
increased, respectively, by RSV or CR. (D) A regulatory network identified by Pathway Studio for seven regulators and their six target genes. Genes shown in blue
and red indicate decreased and increased expression, respectively, by RSV or CR.
and their target genes identiﬁed by Pathway Studio is shown
in Figure 2D. The overlapping network correlated well with
the data identiﬁed by iRegulon. For example, Pathway Studio
identiﬁed EP300 as a positive regulator of LEP, TF, and NQO1.
iRegulon also identiﬁed these three genes as targets of EP300
(Supplementary Table S4, Sheet 2).
Identification of Transcriptional Regulators for
Genes Dysregulated in DIO Zebrafish
We then analyzed transcriptome data of visceral adipose tissues
from female and male (Oka et al., 2010) DIO zebraﬁsh to identify
the network dysregulated in obesity. Although the correlation
of gene expression between female and male DIO zebraﬁsh
was not high (Figure 3A), we identiﬁed 15 genes in common
(Figure 3B, Supplementary Table S1, Sheet 3) between 81
and 473 genes dysregulated in female and male DIO zebraﬁsh,
respectively (Supplementary Table S2, Sheets 6 and 7). Gene
ontology analysis revealed that 111 cell processes, including cell
damage, superoxide anion generation and blood clotting, were
enriched in the 15 genes identiﬁed (Supplementary Table S3,
Sheet 3). iRegulon identiﬁed 14 transcriptional regulators for
the 15 genes (Supplementary Table S4, Sheet 3). The network
between these transcriptional regulators and their target genes
is shown in Figure 3C. Pathway Studio identiﬁed 61 regulators
for the 15 common genes (Supplementary Table S5, Sheet
3). Four regulators were overlapped between the iRegulon and
Pathway Studio data. The network between the four regulators
and their targets is shown in Figure 3D. The overlapping network
correlated well with the data identiﬁed by iRegulon. Pathway
Studio identiﬁed CEBPB as a positive regulator of SERPINA1,
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FIGURE 2 | Identification of the regulatory network of genes with changed expression levels common to RSV and CR in obese humans. (A) Correlation
of gene expression changes by RSV in obese males and CR in obese females (left) or males (middle) and CR in obese females and males (right). (B) Venn diagram of
the numbers of DEG by RSV in obese males, or CR in obese females or males. (C) A regulatory network identified by iRegulon for the seven common genes among
RSV in obese males, and CR in obese females and males. Genes shown in blue and red indicate decreased and increased expression, respectively, by RSV or CR.
(D) A regulatory network identified by Pathway Studio between three regulators and their five target genes. Genes shown in blue and red indicate decreased and
increased expression, respectively, by RSV or CR.
CP, IGFBP1, and FGB, all of which were also identiﬁed as
targets of CEBPB by iRegulon (Supplementary Table S4, Sheet
3).
Identification of Transcriptional Regulators for
Genes Dysregulated in Obese Humans
To identify regulatory network for genes dysregulated in
obese humans, we analyzed the transcriptome data of adipose
tissues from obese human females (Deng et al., 2013) and
males (Tam et al., 2011) deposited to GEO as GSE44000
and GSE29718, respectively. As shown in Figure 4A, the
correlation of gene expression between obese human females
and males was relatively high (r = 0.37, p < 1 × 10−4). We
identiﬁed 46 genes in common (Figure 4B; Supplementary
Table S1, Sheet 4) between 1,736 and 124 genes dysregulated in
obese human females and males, respectively (Supplementary
Table S2, Sheets 8 and 9). Gene ontology analysis revealed
that 350 cell processes, including lipid peroxidation, oxidative
stress, and inﬂammatory response were enriched in the 46
genes (Supplementary Table S3, Sheet 4). Although there was
no overlap between the 15 and 46 common genes in zebraﬁsh
and humans, respectively (Supplementary Table S1, Sheets
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FIGURE 3 | Identification of the regulatory network for genes dysregulated in DIO zebrafish. (A) Correlation of the change in gene expression in DIO female
and male zebrafish. (B) Venn diagram of the numbers of DEG in DIO female and male zebrafish. (C) A regulatory network identified by iRegulon for the 15 common
genes between female and male DIO zebrafish. Genes shown in blue and red indicate decreased and increased expression, respectively, by obesity. (D) A regulatory
network identified by Pathway Studio for four regulators and their eight target genes. Genes shown in blue and red indicate decreased and increased expression,
respectively, by obesity.
3 and 4), 73 gene ontologies were overlapped between the
respective 111 and 350 gene ontologies in zebraﬁsh and
humans (Supplementary Table S3, Sheets 3 and 4). iRegulon
identiﬁed 10 transcriptional regulators for the 46 common
genes (Supplementary Table S4, Sheet 4). The network between
these regulator and their targets is shown in Figure 4C.
Pathway Studio identiﬁed 428 regulators for the 46 common
genes (Supplementary Table S5, Sheet 4). Five regulators were
overlapped between the iRegulon and Pathway Studio data. The
regulatory network between the ﬁve regulators and their 18 target
genes is shown in Figure 4D.
Identification of Common Transcriptional
Regulators Targeted by RSV and CR
To reveal which transcriptional regulators might be involved in
the commonmechanism of RSV and CR, we performed K-Means
clustering (Soukas et al., 2000) of transcriptional regulators
identiﬁed by iRegulon based on their NES (Supplementary
Table S4). As shown in Figure 5A, the K-Means clustering
classiﬁed these transcriptional regulators into seven clusters. The
clustering revealed that HDAC2, CEBPB, and EP300 (Cluster
7) were transcriptional regulators for genes dysregulated in
obesity and normalized by RSV and CR in both DIO zebraﬁsh
and obese human. NR2F2, POLR2A, CEBPD (Cluster 5), and
FOXA1, FOXA2 (Cluster 6) were transcriptional regulators
for genes dysregulated in DIO zebraﬁsh and normalized by
RSV and CR in both DIO zebraﬁsh and obese humans. Gene
ontology analysis revealed that 161 cell processes were enriched
in the eight transcriptional regulators in Clusters 5, 6, and 7
(Supplementary Table S3, Sheet 5). Five cell processes (adipocyte
diﬀerentiation, aging, energy homeostasis, lipid metabolism,
and lipid storage) were overlapped with those enriched in
genes dysregulated in obesity and normalized by RSV and
CR in both DIO zebraﬁsh and obese humans (Supplementary
Table S3, Sheet 6). The network between these transcriptional
regulators and cell processes identiﬁed by Pathway Studio is
shown in Figure 5B. It was demonstrated that EP300 activates
CEBPB, CEBPB, FOXA1, and FOXA2 by acetylation (Wang
et al., 2006, 2013b; Cesena et al., 2007; Kohler and Cirillo,
2010). These ﬁndings suggest that EP300 might be a key
transcriptional regulator involved in the common therapeutic
mechanism of RSV and CR in adipose tissues of obese
individuals.
Inhibition of EP300 Reduces Adiposity in Larval
Zebrafish
The network between EP300 and the target genes identiﬁed by
iRegulon is shown in Figure 6A. It was demonstrated that EP300
increased the expression of TF (Chaudhary and Skinner, 2001),
IGFBP1 (Nasrin et al., 2000), NQO1 (Macoch et al., 2015), and
LEP genes (Cascio et al., 2008). The expression of these genes
increased in obesity (Supplementary Figure S2; Supplementary
Table S1, Sheets 3 and 4) and was normalized by RSV and
CR (Supplementary Figure S2; Supplementary Table S1, Sheets
1 and 2) in adipose tissues of zebraﬁsh and humans. These
results suggest that EP300 might be activated in obesity and
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FIGURE 4 | Identification of the regulatory network for genes dysregulated in obese humans. (A) Correlation of genes dysregulated in adipose tissues from
female and male obese humans. (B) Venn diagram of the numbers of DEG in obese females and males. (C) A regulatory network identified by iRegulon for the 46
common genes between obese females and males. Genes shown in blue and red indicate decreased and increased expression, respectively, by obesity. (D) A
regulatory network identified by Pathway Studio for five regulators and their 18 target genes. Genes shown in blue and red indicate decreased and increased
expression, respectively, by obesity.
that both RSV and CR may suppress the activity of EP300 in
adipose tissues. To examine the eﬀect of EP300 on adiposity,
we used a selective EP300 inhibitor C646 that competes for
AcCoA binding to EP300 (Bowers et al., 2010). As shown in
Figure 6B, the abdominal area of larval zebraﬁsh stained by Nile
Red was signiﬁcantly decreased by 2 μM C646, 200 μM RSV,
or co-treatment of 2 μM C646 and 200 μM RSV. However, the
reduction of adiposity was not signiﬁcantly diﬀerent among the
three treatment groups. These results suggest that the inhibition
of EP300 might be a major therapeutic mechanism of RSV. It
was shown that CR decreased intracellular AcCoA (Marino et al.,
2014) suggesting that CR might inhibit EP300 through reducing
AcCoA.
Discussion
In this study, we demonstrated that the inhibition of EP300might
be common therapeutic mechanism of CR and RSV in adipose
tissues of obese individuals. EP300 is a transcriptional coactivator
with various functions (Wang et al., 2013a), including linking
DNA-bound TF to basal transcription machinery, relaxing
chromatin structure through its histone acetyltransferase activity,
andmodulating the function of various proteins through the lysyl
acetyltransferase activity (Wang et al., 2013a).
It was demonstrated that EP300 acetylated FXR, a master
regulator of lipid homeostasis (Modica et al., 2010) and that
the acetylation of FXR was constitutively activated in obesity
(Kemper et al., 2009). EP300 also activated the transcription
of genes encoding TG synthetic enzymes (Bricambert et al.,
2010). Disrupting the function of EP300 in mice resulted in the
reduction of white adipose tissue and plasma TG (Bedford et al.,
2011). These ﬁndings suggest that EP300 might be activated in
obesity and that the inhibition of EP300 would be a potential
therapeutic strategy in obesity.
It was shown that RSV inhibited EP300 through the activation
of SIRT1 (Shakibaei et al., 2011). When activated, SIRT1
promoted the deacetylation of lysine residues on EP300, resulting
in the inhibition of acetyltransferase activity of EP300 (Kume
et al., 2007). Because SIRT1 is also activated by CR (Guarente,
2013), CR might inhibit EP300 through the activation of SIRT1.
However, CR also decreases intracellular AcCoA through SIRT3
(Hebert et al., 2013). Furthermore, CR inhibited EP300 through
the depletion of AcCoA in the heart and skeletal muscle of mice,
leading to the deacetylation of cellular proteins and activation
of AMP-dependent protein kinase (Marino et al., 2014). These
ﬁndings suggest that EP300 might be inhibited by RSV and
CR in adipose tissues either dependently or independently of
SIRT1.
In this study, we performed comparative transcriptome
analysis of adipose tissues from DIO zebraﬁsh and obese
humans to identify a common therapeutic mechanism of RSV
and CR. There are multiple methods to identify common
pathways using comparative transcriptome analysis. The
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FIGURE 5 | Identification of common transcriptional regulators targeted by RSV and CR. (A) K-Means clustering of regulators identified by iRegulon based
on their NES in each analysis. (B) Network between transcriptional regulators in Clusters 5, 6, and 7 and cellular functions enriched in these transcriptional regulators
and the genes dysregulated in obesity and normalized by RSV or CR.
simplest way is to identify DEG that overlap among diﬀerent
transcriptome data. For example, we identiﬁed 46 DEG that
overlapped between obese human females and males. Among
the DEG, several genes were also identiﬁed as DEG in other
transcriptome analyses not included in this study. These
genes include carboxyl esterase 1 (CES1; Jernas et al., 2009),
NAD(P)H dehydrogenase, quinone 1 (NQO1; Kim et al., 2011),
cathepsin S (CTSS; Lee et al., 2005), matrix metallopeptidase
9 (MMP9; Lee et al., 2005). The expression of these genes was
linked to adiposity (Taleb et al., 2005; Palming et al., 2007;
Jernas et al., 2009), suggesting that the DEG replicated in
multiple transcriptome data is a good and robust marker for
obesity.
However, the lists of DEG do not always overlap between
the same intervention in diﬀerent strains/species or between
related interventions in the same strains/species (Allison et al.,
2006; Antosh et al., 2011). Therefore, the identiﬁcation of
overlapped DEG by comparative transcriptome analysis might
be too stringent, resulting in overlooking important genes and
pathways. To circumvent this, group testing is widely used. For
example, the list of DEG from each transcriptome analysis can be
compared with predeﬁned gene sets related to speciﬁc functions
calculating which gene sets are represented in the list of DEG
at a level greater than that expected by chance alone (Manoli
et al., 2006). By comparing the gene sets signiﬁcantly enriched
in each list of DEG, common pathways can be identiﬁed among
multiple transcriptome data. Using this group analysis, several
pathways have been successfully identiﬁed as common targets
of CR and RSV, including “chromatin assembly or disassembly”
(Barger et al., 2008). Functions related to chromatin were also
identiﬁed as enriched categories in CR by another comparative
transcriptome analysis (Wuttke et al., 2012). In this study, we
performed cis-regulatory sequence analysis as a group analysis
and identiﬁed EP300 as a common therapeutic target of CR and
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FIGURE 6 | Inhibition of EP300 reduces the adiposity in larval zebrafish. (A) Network between EP300 and the target genes identified iRegulon in adipose
tissues of DIO zebrafish and obese humans with and without RES and CR. (B) Changes in the visceral adiposity of zebrafish treated with RES and/or C646. The area
stained with Nile Red is shown compared with that of control (arbitrarily defined as 100%). Values are the means ± SEM. N = 10–12/group. #p < 0.05 vs control.
RSV. Taken together, these ﬁndings suggest that both CR and
RSV may normalize the dysregulation of chromatin functions by
EP300.
We also identiﬁed that the transcriptional regulators CEBPB
and HDAC2 might be common therapeutic targets of RSV
and CR. EP300 interacts with CEBPB at the promoter of
targeted genes (Rastogi et al., 2013) and HDAC2 and EP300
compete for binding to promoters of their target genes
(Meng et al., 2009). Indeed, the binding regions of EP300,
CEBPB, and HDAC2 in the promoters of transferrin (TF;
Supplementary Figure S2), insulin-like growth factor binding
protein 1 (IGFBP1; Supplementary Figure S3) and NQO1
(Supplementary Figure S4), whose expression was increased in
obesity and was normalized by CR or RSV (Figure 6A), overlap.
This might explain why iRegulon identiﬁed CEBPB and HDAC2
as transcriptional regulators. However, we cannot exclude the
possibility that the activity of HDAC2 might be inhibited in
obesity and normalized by CR and RSV. A previous study
reported that mitogen-activated protein kinase phosphatase 3
deﬁcient mice were protected fromDIO and that the activation of
HDAC2 by increased phosphorylation of Ser394 had a major role
in the protection (Feng et al., 2014). Further studies are required
to examine whether HDAC2 is involved in the therapeutic
mechanism of CR and RSV.
Conclusion
We demonstrated that the inhibition of EP300 might be a
common therapeutic mechanism of CR and RSV. To our
knowledge, this is the ﬁrst study to indicate EP300 might
be a potential therapeutic target of CR and RSV in adipose
tissues. Chemicals and natural products that inhibit EP300 might
function as CR mimetics to reduce adiposity in obesity.
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FIGURE S1 | Resveratrol reduces plasma triglyceride and visceral fat in
DIO zebrafish. (A) Changes in BMI (g/cm2) of zebrafish in the control, OF and
OF + RSV groups. Values are means ± SEM, N = 6/group. (B) Changes in
plasma TG levels of zebrafish in the control, OF and OF + RSV groups. Values are
means ± SEM. Control: N = 19, OF: N = 14, OF + RSV: N = 15. (C) Changes in
visceral adiposity of zebrafish in the control, OF and OF + RSV groups. Values are
means ± SEM. N = 9/group. #p < 0.05 vs. control, ∗p < 0.05 vs. OF.
FIGURE S2 | Binding of transcriptional regulators to the human TF gene.
These data were based on the UCSC Genome Browser. The binding of EP300,
HDAC2, and CEBPB are shown as red, blue, or green arrows.
FIGURE S3 | Binding of transcriptional regulators to the human IGFBP1
gene. These data were based on the UCSC Genome Browser. The binding of
EP300, HDAC2, and CEBPB are shown as red, blue, or green arrows.
FIGURE S4 | Binding of transcriptional regulators to the human NQO1
gene. These data were based on the UCSC Genome Browser. The binding of
EP300, HDAC2, and CEBPB are shown as red, blue, or green
arrows.
Table S1 | Genes with changes in expression are common between
multiple datasets. Sheet 1: Genes with changes in expression are common
between RSV and CR in visceral adipose tissue in DIO zebrafish. Sheet 2: Genes
with changes in expression are between RSV and CR in subcutaneous adipose
tissues of obese humans. Sheet 3: Genes dysregulated in visceral adipose tissues
of both female and male DIO zebrafish. Sheet 4: Genes dysregulated in
subcutaneous adipose tissues of obese human females and males.
Table S2 | Differentially expressed genes in each transcriptome dataset.
Sheet 1: Genes regulated by RSV in visceral adipose tissues of female DIO
zebrafish. Sheet 2: Genes regulated by CR in visceral adipose tissues of male DIO
zebrafish. Sheet 3: Genes regulated by RSV in subcutaneous adipose tissues
from obese human males treated with RSV. Sheet 4: Genes regulated by CR in
subcutaneous adipose tissues from obese human females. Sheet 5: Genes
regulated by CR in subcutaneous adipose tissues from obese human males.
Sheet 6: Genes dysregulated in visceral adipose tissues of female DIO zebrafish.
Sheet 7: Genes dysregulated in visceral adipose tissues of male DIO zebrafish.
Sheet 8: Genes dysregulated in subcutaneous adipose tissues of obese human
females. Sheet 9: Genes dysregulated in subcutaneous adipose tissues of obese
human males.
Table S3 | Cell processes enriched in the gene list. Sheet 1: Cell processes
enriched in the common genes between RSV and CR in visceral adipose tissues
of DIO zebrafish. Sheet 2: Cell processes enriched in the common genes between
RSV and CR in subcutaneous adipose tissues of obese humans. Sheet 3: Cell
processes enriched in the common genes dysregulated in visceral adipose tissues
of female and male DIO zebrafish. Sheet 4: Cell processes enriched in the
common genes dysregulated in subcutaneous adipose tissues of obese human
females and males. Sheet 5: Cell processes enriched in HDAC2, EP300, CEBPB,
CEBPD, FOXA1, FOXA2, NR2F2, and POLR2A. Sheet 6: Common cell processes
enriched in genes between RSV and CR, in genes between obese females and
males, and in eight regulators.
Table S4 | Transcriptional regulators identified by iRegulon. Sheet 1:
Transcriptional regulators identified by iRegulon for the common genes between
RSV and CR in visceral adipose tissues of DIO zebrafish. Sheet 2: Transcriptional
regulators identified by iRegulon for the common genes between RSV and CR in
subcutaneous adipose tissues of obese humans. Sheet 3: Transcriptional
regulators identified by iRegulon for genes dysregulated in common between
female and male DIO zebrafish. Sheet 4: Transcriptional regulators identified by
iRegulon for genes dysregulated in common between obese human females and
males.
Table S5 | Transcriptional regulators identified by Pathway Studio. Sheet 1:
Transcriptional regulators identified by Pathway Studio for the common genes
between RSV and CR in visceral adipose tissues of DIO zebrafish. Sheet 2:
Transcriptional regulators identified by Pathway Studio for the common genes
between RSV and CR in subcutaneous adipose tissues of obese humans. Sheet
3: Transcriptional regulators identified by Pathway Studio for the common genes
between female and male DIO zebrafish. Sheet 4: Transcriptional regulators
identified by Pathway Studio for the common genes between female and male
DIO zebrafish.
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